Amgen (AMGN) reported Q3 FY 2020 earnings of $4.37 per share (versus $3.66 per share in Q3 FY 2019), beating analysts’ consensus estimate of $3.74 per share.
The company’s quarterly revenues amounted to $6.423 bln (+12.0% y/y), roughly in line with analysts’ consensus estimate of $6.363 bln.
The company also issued guidance for Q4 FY 2020, projecting EPS of $3.02-3.37 (versus analysts’ consensus estimate of $3.52) and revenues of $6.31-6.71 bln (versus analysts’ consensus estimate of $6.63 bln). For the full FY 2020, it forecast EPS of $15.80-16.15 (versus analysts’ consensus estimate of $15.78) and revenues of $25.1-25.5 bln (versus analysts’ consensus estimate of $25.39 bln).
AMGN closed Wednesday's trading session at $216.38 (-3.17%).